News Releases

Date	Title	Document
Date Mar 20, 2026	Title iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference	Document PDF
Date Mar 13, 2026	Title Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score	Document PDF
Date Mar 03, 2026	Title Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission	Document PDF
Date Feb 11, 2026	Title iMDx Announces $26.0 Million Registered Direct Offering	Document PDF
Date Jan 13, 2026	Title IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring	Document PDF
Date Jan 07, 2026	Title iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation	Document PDF
Date Jan 06, 2026	Title iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch	Document PDF
Date Jan 05, 2026	Title iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion	Document PDF